188 related articles for article (PubMed ID: 6891873)
1. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
Lösse B; Kuhn H; Loogen F
Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
[No Abstract] [Full Text] [Related]
2. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
Lösse B; Loogen F; Schulte HD
Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
[TBL] [Abstract][Full Text] [Related]
3. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
Crittin J; Mayor C; Bloch A
Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
[TBL] [Abstract][Full Text] [Related]
4. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
[TBL] [Abstract][Full Text] [Related]
5. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
Haberer T; Hess OM; Jenni R; Krayenbühl HP
Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
[TBL] [Abstract][Full Text] [Related]
6. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
[TBL] [Abstract][Full Text] [Related]
7. [Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].
Nowalany-Kozielska E; Wodniecki J; Tendera M; Poloński L
Kardiol Pol; 1987; 30(7):409-18. PubMed ID: 3316787
[No Abstract] [Full Text] [Related]
8. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
[No Abstract] [Full Text] [Related]
9. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
Korovina EP
Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
[TBL] [Abstract][Full Text] [Related]
10. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
[No Abstract] [Full Text] [Related]
11. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
[No Abstract] [Full Text] [Related]
12. Hypertrophic occlusive cardiomyopathy.
Kaltenbach M; Hopf R
Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
[No Abstract] [Full Text] [Related]
13. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
[TBL] [Abstract][Full Text] [Related]
14. [Risk of stress-induced ventricular arrhythmias in hypertrophic cardiomyopathy].
Lösse B; Christoph I; Borggrefe M; Königer HH
Z Kardiol; 1984 May; 73(5):304-12. PubMed ID: 6541405
[TBL] [Abstract][Full Text] [Related]
15. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
Masini V; Ceci V; Malinconico U; Milazzotto F
G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
[No Abstract] [Full Text] [Related]
18. [Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin].
Kisliak OA; Storozhakov GI
Kardiologiia; 1984 Aug; 24(8):27-30. PubMed ID: 6238196
[TBL] [Abstract][Full Text] [Related]
19. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
[No Abstract] [Full Text] [Related]
20. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
